Adipocyte-derived hormone levels in HIV lipodystrophy

Area of Science:

• Endocrinology
• Metabolic Syndrome
• HIV Medicine

Background:

• Adipocyte-derived hormones like leptin and adiponectin are crucial in regulating insulin sensitivity.
• Human lipodystrophic states, particularly those associated with HIV, present complex metabolic challenges.
• Understanding hormone levels in these conditions is vital for managing insulin resistance.

Purpose of the Study:

• To investigate the plasma levels of leptin and adiponectin in individuals with HIV lipodystrophy.
• To explore the associations between these hormone levels, fat distribution, and insulin sensitivity.
• To elucidate the role of adiponectin in the insulin resistance observed in HIV lipodystrophy.

Main Methods:

• A cross-sectional study was conducted involving HIV-infected men with and without lipodystrophy, alongside healthy controls.
• Fasting plasma levels of leptin and adiponectin were measured.
• Body composition was assessed using physical examination, DXA, and CT scans, while insulin sensitivity was determined via an insulin-modified frequently sampled intravenous glucose tolerance test.

Main Results:

• HIV-infected men with lipodystrophy exhibited significantly higher leptin levels compared to HIV-infected controls.
• Adiponectin levels were markedly lower in HIV-infected men with lipodystrophy compared to both HIV-infected and healthy controls.
• Adiponectin levels were positively correlated with insulin sensitivity in HIV-infected patients, independent of fat mass.

Conclusions:

• Plasma leptin and adiponectin levels are significantly altered in the HIV lipodystrophy syndrome.
• Adiponectin deficiency appears to be a key factor contributing to the insulin resistance associated with HIV lipodystrophy.
• Targeting adiponectin may offer a therapeutic strategy for managing metabolic complications in this patient population.